North Carolina Senate Passes Medical Cannabis Bill

The North Carolina Senate approved the state’s medical cannabis legalization proposal; it’s the second year in a row that senators have approved medical cannabis reforms.

Full story after the jump.

The North Carolina Senate on Tuesday passed a medical cannabis legalization bill, WRAL reports. It marks the second year in a row the chamber has approved a medical cannabis bill; however, the measure died in the House in 2022.

The bill received bipartisan support, passing by a 36-10 margin. The legislation is largely the same as the measure that passed the Senate by a 36-7 vote last year.

Republican state Sen. Bill Rabon, the bill’s lead sponsor, told WRAL that he believes the reforms have more support in the House this year. The measure was never brought up for a vote in 2022.

“The purpose of the bill is to allow for tightly regulated use of medical cannabis, only by those with debilitating illnesses … The recreational sale or use of marijuana remains, under this legislation, illegal.” — Rabon, during the Senate debate, via WRAL

The qualifying conditions list to allow patients to access medical cannabis includes cancer, epilepsy, HIV, AIDS, amyotrophic lateral sclerosis (ALS), Crohn’s disease, sickle cell anemia, Parkinson’s disease, post-traumatic stress disorder (PTSD), multiple sclerosis, cachexia or wasting syndrome, severe or persistent nausea in a person who is not pregnant that is related to end-of-life or hospice care, or who is bedridden or homebound because of a condition, terminal illness when the patient’s remaining life expectancy is less than six months, and conditions resulting in the individual receiving hospice care, according to the bill text.

The Senate-approved version includes stricter rules on marketing than the previous version, allowing 10 companies to sell medical cannabis with a maximum of eight stores each. The measure moves next to the House after a second, confirmation vote on Wednesday.

Get daily cannabis business news updates. Subscribe

Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.


Latest Cannabis News

View all news Get email updates

Featured Business Profiles

Create a profile View all categories

From Our Partners